Wintergerst et al. reported that GALNS mRNA expression can predict the prognosis of head and neck squamous cell carcinoma patients after adjuvant radiotherapy or chemotherapy [9]. This evidence concerns the gene GALNS and head and neck squamous cell carcinoma.